RAPPORT THERAPEUTICS INC (RAPP) Stock Cash Flow
NASDAQ:RAPP - Nasdaq - US75383L1026 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -79.64M | -78.31M | -34.79M | -10.65M | |||
| Depreciation Amortization | 930.00K | 840.00K | 110.00K | 15.00K | |||
| Change In Working Capital | 310.00K | -2.42M | 2.65M | 1.49M | |||
| Other non cash items | 10.96M | 15.00M | 4.84M | 5.91M | |||
| OPERATING CASH FLOW | -67.00M | -65.00M | -27.00M | -3.24M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -1.63M | -2.41M | -1.64M | -284.00K | |||
| Other Investing Activity | -106.00M | -168.00M | -77.00M | -5.00M | |||
| INVESTING CASH FLOW | -107.00M | -170.00M | -79.00M | -5.28M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 8.00M | |||
| Stock Issued/Repurchased | 158.01M | 222.00M | 85.00M | 31.00K | |||
| Other Financing Activity | N/A | 0.00 | 60.00M | 31.65M | |||
| FINANCING CASH FLOW | 158.01M | 222.00M | 145.00M | 39.69M | |||
| CHANGE IN CASH | -15.99M | -13.00M | 39.00M | 31.16M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -67.00M | -65.00M | -27.00M | -3.24M | |||
| Capital Expenditure | -1.63M | -2.41M | -1.64M | -284.00K | |||
| FREE CASH FLOW | -68.63M | -67.41M | -28.64M | -3.53M | |||
All data in USD